Frontiers | In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons | Cell and Developmental Biology
Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies | Nature
Antibodies against alpha‐synuclein: tools and therapies - Vaikath - 2019 - Journal of Neurochemistry - Wiley Online Library
Propagation of α-Synuclein Strains within Human Reconstructed Neuronal Network - ScienceDirect
Cryo-EM of full-length α-synuclein reveals fibril polymorphs with a common structural kernel | Nature Communications
PDF) Structural and functional characterization of two a-synuclein strains
Evidence of distinct α-synuclein strains underlying disease heterogeneity | SpringerLink
Evidence of distinct α-synuclein strains underlying disease heterogeneity | SpringerLink
α-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb | Acta Neuropathologica Communications | Full Text
Neurodegenerative diseases distinguished through protein-structure analysis
Frontiers | New Perspectives on Roles of Alpha-Synuclein in Parkinson's Disease | Frontiers in Aging Neuroscience
α-Synuclein strains target distinct brain regions and cell types | Nature Neuroscience
Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies - ScienceDirect
α-Synuclein strains cause distinct synucleinopathies after local and systemic administration | Nature
Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons: Cell
Alpha-synuclein stepwise aggregation reveals features of an early onset mutation in Parkinson's disease | Communications Biology
The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies | SpringerLink
A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity | PNAS
Stabilization of α-synuclein oligomers using formaldehyde
Frontiers | Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease | Frontiers in Molecular Neuroscience
Molecules | Free Full-Text | Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro | HTML
A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity | PNAS
Exposure to bacterial endotoxin generates a distinct strain of α-synuclein fibril | Scientific Reports
Molecular and Biological Compatibility with Host Alpha-Synuclein Influences Fibril Pathogenicity - ScienceDirect
